Targeted Perfusion Based Haemodynamic Management in Critically Ill Patients Using Urethral Perfusion

• Status: Recruiting
• Trial end date: 2024-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the safety and feasibility of the IKORUS device in critically ill patients and to gather exploratory data on haemodynamic coherence

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: King's College Hospital NHS Trust

Criteria

Inclusion Criteria:

• Within 24 h of ICU admission

• Predicted length of ICU stay at least 5 days

• Receiving >0.1 mcg/kg/min of noradrenaline at time of study enrolment

Exclusion Criteria:

• Palliative treatment intent

• Contra indication to urethral catheterisation or complication during previous urethral catheter insertion

• Contraindication to fluid or vasopressor challenges in the opinion of the attending clinician